COGT logo

Cogent Biosciences, Inc. (COGT) Cash From Operations

Annual CFO:

-$207.79M-$54.17M(-35.26%)
December 31, 2024

Summary

  • As of today, COGT annual cash from operations is -$207.79 million, with the most recent change of -$54.17 million (-35.26%) on December 31, 2024.
  • During the last 3 years, COGT annual cash from operations has fallen by -$149.03 million (-253.61%).
  • COGT annual cash from operations is now -1272.90% below its all-time high of $17.72 million, reached on December 31, 2015.

Performance

COGT Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTcash flow metrics

Quarterly CFO:

-$54.54M+$11.97M(+18.00%)
June 30, 2025

Summary

  • As of today, COGT quarterly cash from operations is -$54.54 million, with the most recent change of +$11.97 million (+18.00%) on June 30, 2025.
  • Over the past year, COGT quarterly cash from operations has dropped by -$11.84 million (-27.73%).
  • COGT quarterly cash from operations is now -846.75% below its all-time high of -$5.76 million, reached on June 30, 2017.

Performance

COGT Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTcash flow metrics

TTM CFO:

-$233.61M-$11.84M(-5.34%)
June 30, 2025

Summary

  • As of today, COGT TTM cash from operations is -$233.61 million, with the most recent change of -$11.84 million (-5.34%) on June 30, 2025.
  • Over the past year, COGT TTM cash from operations has dropped by -$56.34 million (-31.78%).
  • COGT TTM cash from operations is now -3114.28% below its all-time high of -$7.27 million, reached on March 31, 2017.

Performance

COGT TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

COGT Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-35.3%-27.7%-31.8%
3Y3 Years-253.6%-106.2%-160.5%
5Y5 Years-400.5%-555.2%-568.8%

COGT Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-253.6%at low-85.5%+18.0%-112.4%at low
5Y5-Year-479.6%at low-482.3%+18.0%-568.8%at low
All-TimeAll-Time-1272.9%at low-846.8%+18.0%-3114.3%at low

COGT Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2025
-
-$54.54M(+18.0%)
-$233.61M(-5.3%)
Mar 2025
-
-$66.51M(-9.8%)
-$221.77M(-6.7%)
Dec 2024
-$207.79M(-35.3%)
-$60.58M(-16.5%)
-$207.79M(-8.6%)
Sep 2024
-
-$51.98M(-21.7%)
-$191.28M(-7.9%)
Jun 2024
-
-$42.70M(+18.7%)
-$177.27M(-6.4%)
Mar 2024
-
-$52.53M(-19.2%)
-$166.64M(-8.5%)
Dec 2023
-$153.62M(-29.5%)
-$44.07M(-16.1%)
-$153.62M(-10.6%)
Sep 2023
-
-$37.97M(-18.4%)
-$138.96M(-2.6%)
Jun 2023
-
-$32.07M(+18.9%)
-$135.43M(-4.3%)
Mar 2023
-
-$39.52M(-34.4%)
-$129.82M(-9.4%)
Dec 2022
-$118.64M(-101.9%)
-$29.41M(+14.6%)
-$118.64M(-7.8%)
Sep 2022
-
-$34.44M(-30.2%)
-$110.01M(-22.7%)
Jun 2022
-
-$26.46M(+6.6%)
-$89.68M(-18.4%)
Mar 2022
-
-$28.33M(-36.4%)
-$75.73M(-28.9%)
Dec 2021
-$58.76M(-63.9%)
-$20.78M(-47.3%)
-$58.76M(-24.1%)
Sep 2021
-
-$14.11M(-12.8%)
-$47.35M(-8.8%)
Jun 2021
-
-$12.51M(-10.1%)
-$43.51M(-10.6%)
Mar 2021
-
-$11.37M(-21.4%)
-$39.32M(-9.7%)
DateAnnualQuarterlyTTM
Dec 2020
-$35.85M(+13.6%)
-$9.37M(+8.8%)
-$35.85M(-2.6%)
Sep 2020
-
-$10.27M(-23.3%)
-$34.93M(-0.2%)
Jun 2020
-
-$8.32M(-5.5%)
-$34.87M(+8.0%)
Mar 2020
-
-$7.89M(+6.5%)
-$37.89M(+8.7%)
Dec 2019
-$41.51M(-27.8%)
-$8.45M(+17.3%)
-$41.51M(+1.4%)
Sep 2019
-
-$10.21M(+10.0%)
-$42.09M(-6.7%)
Jun 2019
-
-$11.34M(+1.5%)
-$39.46M(-9.5%)
Mar 2019
-
-$11.52M(-27.7%)
-$36.03M(-10.9%)
Dec 2018
-$32.49M(-25.8%)
-$9.02M(-19.1%)
-$32.49M(-8.4%)
Sep 2018
-
-$7.58M(+4.3%)
-$29.98M(-4.5%)
Jun 2018
-
-$7.91M(+0.9%)
-$28.70M(-8.1%)
Mar 2018
-
-$7.98M(-22.5%)
-$26.55M(-2.8%)
Dec 2017
-$25.84M(-38.6%)
-$6.52M(-3.6%)
-$25.84M(-33.7%)
Sep 2017
-
-$6.29M(-9.2%)
-$19.32M(-48.3%)
Jun 2017
-
-$5.76M(+20.7%)
-$13.03M(-79.3%)
Mar 2017
-
-$7.27M
-$7.27M
Dec 2016
-$18.64M(-205.2%)
-
-
Dec 2015
$17.72M
-
-

FAQ

  • What is Cogent Biosciences, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. annual cash from operations year-on-year change?
  • What is Cogent Biosciences, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. quarterly cash from operations year-on-year change?
  • What is Cogent Biosciences, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. TTM cash from operations year-on-year change?

What is Cogent Biosciences, Inc. annual cash from operations?

The current annual cash from operations of COGT is -$207.79M

What is the all-time high annual cash from operations for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high annual cash from operations is $17.72M

What is Cogent Biosciences, Inc. annual cash from operations year-on-year change?

Over the past year, COGT annual cash from operations has changed by -$54.17M (-35.26%)

What is Cogent Biosciences, Inc. quarterly cash from operations?

The current quarterly cash from operations of COGT is -$54.54M

What is the all-time high quarterly cash from operations for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high quarterly cash from operations is -$5.76M

What is Cogent Biosciences, Inc. quarterly cash from operations year-on-year change?

Over the past year, COGT quarterly cash from operations has changed by -$11.84M (-27.73%)

What is Cogent Biosciences, Inc. TTM cash from operations?

The current TTM cash from operations of COGT is -$233.61M

What is the all-time high TTM cash from operations for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high TTM cash from operations is -$7.27M

What is Cogent Biosciences, Inc. TTM cash from operations year-on-year change?

Over the past year, COGT TTM cash from operations has changed by -$56.34M (-31.78%)
On this page